Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Panadom-DSR
- Development stage
- Unknown
- Lead developer
- MetaneX Life Science
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Panadom-DSR is a fixed-dose combination pharmaceutical product developed and marketed by MetaneX Life Science. It contains two active ingredients: pantoprazole, a proton pump inhibitor (PPI), and domperidone, a dopamine antagonist with prokinetic properties. Pantoprazole works by irreversibly inhibiting the H+/K+-ATPase enzyme system (the proton pump) in the gastric parietal cells, thereby suppressing stomach acid production. Domperidone acts as a peripheral dopamine D2 receptor antagonist, which enhances gastric motility and increases lower esophageal sphincter pressure, facilitating gastric emptying. This combination is primarily used for the management of gastroesophageal reflux disease (GERD) and peptic ulcer disease, particularly in patients who experience symptoms of dyspepsia, nausea, or vomiting alongside acid reflux.
- Brand names
- Panadom-DSR
- Other names
- Pantoprazole and Domperidone Sustained Release Capsules
02
Targets
ATP4A (Potassium–transporting ATPase alpha chain 1)DRD2 (Dopamine D2 Receptor)
Beyond the preview
Go deeper on Panadom-DSR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Panadom-DSR.